We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
CERT icon
351
Certara
CERT
$1.21B
$1.21B $7.80 4.65%
VOR icon
352
Vor Biopharma
VOR
$1.21B
$1.21B $22.25 3.92%
STAA icon
353
STAAR Surgical
STAA
$1.2B
$1.2B $24.12 0.9%
OMDA
354
Omada Health Inc
OMDA
$1.2B
$1.2B $20.18 1.61%
QDEL icon
355
QuidelOrtho
QDEL
$1.2B
$1.2B $17.58 0.73%
IRMD icon
356
iRadimed
IRMD
$1.19B
$1.19B $93.13 1.71%
WVE icon
357
Wave Life Sciences
WVE
$1.18B
$1.18B $6 4.53%
DRTS icon
358
Alpha Tau Medical
DRTS
$1.18B
$1.18B $13.08 9.73%
CRVS icon
359
Corvus Pharmaceuticals
CRVS
$1.17B
$1.17B $13.92 4.11%
SDGR icon
360
Schrodinger
SDGR
$1.17B
$1.17B $15.65 2.42%
COLL icon
361
Collegium Pharmaceutical
COLL
$1.16B
$1.16B $35.73 0.42%
FRNM
362
Freenome, Inc. Common stock
FRNM
$1.16B
$1.16B $10.91 0.91%
USPH icon
363
US Physical Therapy
USPH
$1.15B
$1.15B $75.86 2.51%
SPTX
364
Seaport Therapeutics
SPTX
$1.15B
$1.15B $21.43 3.78%
MGTX icon
365
MeiraGTx Holdings
MGTX
$1.14B
$1.14B $12.29 3.45%
GDRX icon
366
GoodRx Holdings
GDRX
$1.13B
$1.13B $3.34 5.7%
SVRA icon
367
Savara
SVRA
$1.11B
$1.11B $5.41 1.5%
LXRX icon
368
Lexicon Pharmaceuticals
LXRX
$1.11B
$1.11B $2.49 6.87%
ANRO icon
369
Alto Neuroscience
ANRO
$1.1B
$1.1B $28.23 3.52%
LMRI
370
Lumexa Imaging Holdings
LMRI
$1.09B
$1.09B $11.35 0.8%
PCRX icon
371
Pacira BioSciences
PCRX
$1.09B
$1.09B $27.62 2.6%
NUTX
372
Nutex Health
NUTX
$1.09B
$1.09B $157.80 3.18%
CGEM icon
373
Cullinan Oncology
CGEM
$1.08B
$1.08B $17.55 8%
IVA
374
Inventiva
IVA
$1.07B
$1.07B $4.51 6.12%
CRON
375
Cronos Group
CRON
$1.05B
$1.05B $2.81 0.71%

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,066 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $8.94T.

The largest by market cap are Eli Lilly (LLY) at $995B, Johnson & Johnson (JNJ) at $614B and AbbVie (ABBV) at $431B.

Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.

  • Combined market cap: $8.94T across 1,066 stocks.
  • Largest constituent: Eli Lilly (LLY), $995B market cap.
  • Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.